Therapeutics

Novartis, Gilead Sciences, Spark Therapeutics, Amgen, Orchard Therapeutics, Bristol-Myers Squibb, BioMarin, PTC Therapeutics, and Organogenesis are the leading players in the cell and gene therapy market.

Altamira Therapeutics Ltd. engages in developing therapeutics that address various unmet medical needs.

Receive News & Ratings for Entrada Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Entrada Therapeutics and related companies with MarketBeat.

Receive News & Ratings for Trevi Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trevi Therapeutics and related companies with MarketBeat.

Stoke Therapeutics, Inc. () – Cantor Fitzgerald lifted their FY2023 earnings per share estimates for Stoke Therapeutics in a report released on Tuesday, March 7th.

Fresh Tracks Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States.

Guided Therapeutics competitors beat Guided Therapeutics on 6 of the 10 factors compared.

Mirati Therapeutics, Inc, a commercial-stage oncology company, develops novel therapeutics to address the genetic and immunological promoters of cancer in the United States.

Oruka Therapeutics, Inc. () – Stock analysts at Leerink Partnrs issued their FY2028 EPS estimates for shares of Oruka Therapeutics in a research note issued on Wednesday, November 13th.

Panbela Therapeutics () and Tango Therapeutics () are both small-cap medical companies, but which is the better business?

Receive News & Ratings for Aileron Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aileron Therapeutics and related companies with MarketBeat.

Receive News & Ratings for Cullinan Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cullinan Therapeutics and related companies with MarketBeat.

Receive News & Ratings for Iterum Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Iterum Therapeutics and related companies with MarketBeat.

Receive News & Ratings for TG Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TG Therapeutics and related companies with MarketBeat.

Given Medicenna Therapeutics’ rivals higher possible upside, analysts plainly believe Medicenna Therapeutics has less favorable growth aspects than its rivals.

In other RAPT Therapeutics news, insider Dirk G. Brockstedt sold 9,877 shares of RAPT Therapeutics stock in a transaction dated Friday, May 15th.

Intellia Therapeutics is a leading genome editing company focused on developing proprietary, curative therapeutics using the CRISPR/Cas9 system.

Knight Therapeutics Inc (TSE:GUD) – Investment analysts at National Bank Financial cut their FY2020 earnings per share estimates for Knight Therapeutics in a research report issued on Sunday, June 28th.

Neoleukin Therapeutics is trading at a lower price-to-earnings ratio than Bellerophon Therapeutics, indicating that it is currently the more affordable of the two stocks.

Receive News & Ratings for Aclaris Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aclaris Therapeutics and related companies with MarketBeat.